Gan & Lee Pharmaceuticals. (SHA: 603087)

Gan & Lee Pharmaceuticals. Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	23,591	31,066	18,429	39,499	74,247	-
Market Cap Growth	27.93%	68.57%	-53.34%	-46.80%	-	-
Enterprise Value	18,728	26,918	13,463	34,935	70,382	-
Last Close Price	39.51	52.43	32.44	69.59	130.39	-
PE Ratio	45.42	87.38	-41.59	26.87	56.45	-
PS Ratio	8.51	11.91	10.76	10.94	22.08	-
PB Ratio	2.06	2.89	1.92	3.88	8.31	-
P/FCF Ratio	-89.41	-70.03	-26.83	102.30	112.63	-
P/OCF Ratio	118.27	283.83	62.12	36.63	59.81	-
EV/Sales Ratio	6.95	10.32	7.86	9.67	20.94	-
EV/EBITDA Ratio	41.95	68.22	-28.06	22.24	44.70	-
EV/EBIT Ratio	90.02	149.52	-19.93	25.13	49.75	-
EV/FCF Ratio	-60.55	-60.68	-19.60	90.48	106.77	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	-
Debt / EBITDA Ratio	0.01	0.02	-	0.01	-	-
Debt / FCF Ratio	-0.02	-0.02	-0.02	0.04	-	-
Asset Turnover	0.24	0.23	0.16	0.35	0.43	0.54
Inventory Turnover	0.88	0.96	0.68	0.70	0.64	0.55
Quick Ratio	6.89	6.77	6.05	12.65	13.14	5.66
Current Ratio	8.29	7.98	6.97	14.15	14.54	6.79
Return on Equity (ROE)	4.87%	3.35%	-4.45%	15.21%	17.08%	23.97%
Return on Assets (ROA)	1.15%	1.01%	-3.94%	8.54%	11.38%	15.50%
Return on Capital (ROIC)	1.25%	1.11%	-4.27%	9.09%	12.27%	17.05%
Earnings Yield	2.20%	1.09%	-2.38%	3.68%	1.66%	-
FCF Yield	-1.31%	-1.43%	-3.73%	0.98%	0.89%	-
Dividend Yield	0.51%	0.38%	-	0.43%	0.31%	-
Payout Ratio	20.09%	-	-	15.46%	16.30%	-
Buyback Yield / Dilution	-3.51%	-0.59%	-0.46%	-5.28%	-5.43%	-0.09%
Total Shareholder Return	-3.00%	-0.20%	-0.46%	-4.85%	-5.13%	-0.09%

Source: S&P Capital IQ. Standard template. Financial Sources.